Track topics on Twitter Track topics that are important to you
A few companies have taken big strides in moving their biosimilar portfolios forward in Europe and the…
Original Article: Sandoz flexes its biosimilar muscles with Humira and Rituxan dataNEXT ARTICLE
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...